Acute Beneficial Effects of a Rho-Kinase Inhibitor, Fasudil in Patients With Pulmonary Hypertension Due to Left Heart Disease

被引：0
|
作者：
Ishiyama, Masaki
Fujimoto, Naoki
Sato, Toru
Omori, Taku
Moriwaki, Keishi
Sugiura, Emiyo
Ogihara, Yoshito
Nakamori, Shiro
Kurita, Tairo
Dohi, Kaoru
机构：
来源：
CIRCULATION | 2022年 / 146卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A13710
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Effects of a Rho-Kinase Inhibitor in Patients With Pulmonary Hypertension Due to Left Heart Disease
    Ishiyama, Masaki
    Fujimoto, Naoki
    Fukuoka, Shusuke
    Omori, Taku
    Moriwaki, Keishi
    Ogihara, Yoshito
    Nakamori, Shiro
    Kurita, Tairo
    Okamoto, Ryuji
    Dohi, Kaoru
    JACC-HEART FAILURE, 2024, 12 (02) : 409 - 411
  • [2] Effects of the Rho-Kinase Inhibitor, Fasudil, on Pulmonary Hypertension
    Odagiri, Keiichi
    Watanabe, Hiroshi
    CIRCULATION JOURNAL, 2015, 79 (06) : 1213 - 1214
  • [3] Acute Effects of Rho-Kinase Inhibitor Fasudil on Pulmonary Arterial Hypertension in Patients With Congenital Heart Defects
    Xiao, Jia-wang
    Zhu, Xian-yang
    Wang, Qi-guang
    Zhang, Duan-zhen
    Cui, Chun-sheng
    Zhang, Po
    Chen, Huo-yuan
    Meng, Li-li
    CIRCULATION JOURNAL, 2015, 79 (06) : 1342 - 1348
  • [4] Acute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertension
    Fukumoto, Y
    Matoba, T
    Ito, A
    Tanaka, H
    Kishi, T
    Hayashidani, S
    Abe, K
    Takeshita, A
    Shimokawa, H
    HEART, 2005, 91 (03) : 391 - 392
  • [5] Beneficial acute effects of Rho-kinase inhibitor in patients with pulmonary arterial hypertension
    Ishikura, K
    Yamada, N
    Ito, M
    Ota, S
    Nakamura, M
    Isaka, N
    Nakano, T
    CIRCULATION JOURNAL, 2006, 70 (02) : 174 - 178
  • [6] Acute vasodilator effects of inhaled fasudil, a specific Rho-kinase inhibitor, in patients with pulmonary arterial hypertension
    Hiroshi Fujita
    Yoshihiro Fukumoto
    Kenya Saji
    Koichiro Sugimura
    Jun Demachi
    Jun Nawata
    Hiroaki Shimokawa
    Heart and Vessels, 2010, 25 : 144 - 149
  • [7] Acute vasodilator effects of inhaled fasudil, a specific Rho-kinase inhibitor, in patients with pulmonary arterial hypertension
    Fujita, Hiroshi
    Fukumoto, Yoshihiro
    Saji, Kenya
    Sugimura, Koichiro
    Demachi, Jun
    Nawata, Jun
    Shimokawa, Hiroaki
    HEART AND VESSELS, 2010, 25 (02) : 144 - 149
  • [8] Attenuation of Pulmonary Hypertension Secondary to Left Ventricular Dysfunction in the Rat by Rho-Kinase Inhibitor Fasudil
    Dai, Zen-Kong
    Wu, Bin-Nan
    Chen, I-Chen
    Chai, Chee-Yin
    Wu, Jiunn-Ren
    Chou, Shah-Hwa
    Yeh, Jwu-Lai
    Chen, Ing-Jun
    Tan, Mian-Shin
    PEDIATRIC PULMONOLOGY, 2011, 46 (01) : 45 - 59
  • [9] Rho-kinase inhibitor, fasudil, reduces pulmonary vascular resistance in patients with severe pulmonary hypertension
    Fukumoto, Y
    Matoba, T
    Abe, K
    Ito, A
    Shimokawa, H
    CIRCULATION, 2003, 108 (17) : 525 - 525
  • [10] Intravenous administration of a Rho-kinase inhibitor, fasudil, reduces pulmonary vascular resistance in patients with pulmonary hypertension
    Fukumoto, Y
    Hirakawa, Y
    Abe, K
    Koike, G
    Mohri, M
    Shimokawa, H
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 170 - 171
12345